Cargando…

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights

Detalles Bibliográficos
Autores principales:	Van Elslande, Jan, André, Emmanuel, Van Ranst, Marc, Lagrou, Katrien, Vermeersch, Pieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833516/ https://www.ncbi.nlm.nih.gov/pubmed/33137289 http://dx.doi.org/10.1016/S1473-3099(20)30846-X

Ejemplares similares

Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs
por: Van Elslande, Jan, et al.
Publicado: (2020)

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
por: Van Elslande, Jan, et al.
Publicado: (2021)

Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
por: Van Elslande, Jan, et al.
Publicado: (2022)

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients
por: Van Elslande, J., et al.
Publicado: (2020)

IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
por: Decru, Bram, et al.
Publicado: (2022)

Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workers
por: Decru, Bram, et al.
Publicado: (2022)

Air conditioning system usage and SARS-CoV-2 transmission dynamics in Iran
por: Pourkarim, Mahmoud Reza, et al.
Publicado: (2020)

IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination
por: Van Elslande, Jan, et al.
Publicado: (2022)

Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in a Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine
por: Van Elslande, Jan, et al.
Publicado: (2022)

Transient Increase of Pre-existing Anti-IFN-α2 Antibodies Induced by SARS-CoV-2 Infection
por: Steels, Sophie, et al.
Publicado: (2022)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

Migrating a lab-developed MERS-CoV real-time PCR to 3 “Sample to Result” systems: experiences on optimization and validation
por: Frans, Glynis, et al.
Publicado: (2019)

Analytical Performance of the RIDASCREEN(®) Hantavirus Puumala IgG/IgM ELISA Assay
por: Depypere, Melissa, et al.
Publicado: (2020)

Letter to the editor: The first tick-borne encephalitis case in the Netherlands: reflections and a note of caution
por: Clement, Jan, et al.
Publicado: (2016)

Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
por: Chapuy-Regaud, Sabine, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
por: Stringhini, Silvia, et al.
Publicado: (2021)

No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1
por: Prasad, Mukul, et al.
Publicado: (2021)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
por: Romero, Carolina, et al.
Publicado: (2021)

Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab
por: Antonelli, Guido, et al.
Publicado: (2021)

Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Laboratory information system requirements to manage the COVID-19 pandemic: A report from the Belgian national reference testing center
por: Weemaes, Matthias, et al.
Publicado: (2020)

Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance
por: Perez-Saez, Javier, et al.
Publicado: (2021)

A comparison of 7 commercial anti-SARS-CoV-2 antibody immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2020)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
por: Romero, Carolina, et al.
Publicado: (2022)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

A case of severe pseudohyperkalaemia due to muscle contraction
por: Van Elslande, Jan, et al.
Publicado: (2020)

Comment on “A Cluster of Three Cases of Hantavirus Pulmonary Syndrome among Canadian Military Personnel”
por: Clement, Jan, et al.
Publicado: (2016)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Qualitative immunoassay for the detection of anti-SARS-COV-2 spike antibody in human milk samples
por: Yang, Xiaoqi, et al.
Publicado: (2022)

Potential for false decline of anti-SARS-CoV-2 spike antibody titers after COVID-19 vaccination
por: Waldman, Meryl, et al.
Publicado: (2022)

Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies
por: Bong, Ji-Hong, et al.
Publicado: (2021)

Delayed diagnosis and treatment of extreme hypertriglyceridemia due to rejection of a lipemic sample
por: Van Elslande, Jan, et al.
Publicado: (2021)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
por: Roarty, Cathal, et al.
Publicado: (2021)

The presence of SARS-CoV2 antibodies in MS patients
por: Wallach, Asya I., et al.
Publicado: (2021)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nu6tflka4b8f8ltjk0qjl3ip2j